InvestorsHub Logo
Followers 4
Posts 326
Boards Moderated 0
Alias Born 10/19/2005

Re: None

Thursday, 12/20/2012 11:08:52 AM

Thursday, December 20, 2012 11:08:52 AM

Post# of 130507
Dr. Rubinfeld Presenting...Wow!

"Thereafter, current Amarantus advisor Dr. Joseph Rubinfeld will provide his views on areas of significant commercial potential for MANF beyond Parkinson's disease."

If anyone doesn't think a partnership deal is in the works they're crazy.

We have the co-founder of Amgen presenting on the commercial potential of MANF beyond PD. He has previously stated that "MANF could be the biggest success I have ever seen". We also have senior execs from Bayer and Bristol Myers as well as a prior president of the American Medical Association Foundation on the board.

We have Hermo Pharma, a MJFF grant recipient and VC backed bio tech firm, that felt compelled to challenge the company's MANF patents because they cause undue burden on anyone trying to test it (i.e., they will have to go through AMBS if they want to) and lost.

We have a drug that has shown significantly better results than another drug that at the same exact stage it is at was bought for $250 Million.

I completely understand why people want to take profits. Do you want to listen to college kids bash the stock like ALL-IN or golong or do you want to listen to the co-founder of Amgen or the president of the American Medical Association Foundation or an executive from Bayer all say how MANF could be a huge success?

The ones that can hold through the ups and downs will make out like bandits with this company.